| Description |
Tafasitamab (XmAb5574) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigenCD19. |
| Cat.No |
A741 |
| Name |
Tafasitamab |
Chemical Properties
| CAS |
1422527-84-1 |
|
| Synonyms |
MOR 00208;Monjuvi;Tafasitamab;Research Grade Tafasitamab(DHD10803);Research Grade Tafasitamab(DHD10803);Research Grade Tafasitamab;Research Grade Tafasitamab;Tafasitamab (anti-CD19);Tafasitamab (anti-CD19);MOR00208|||XmAb5574|||Tafasitamab-cxix;MOR00208|||XmAb5574|||Tafasitamab-cxix |
| pH value |
Corresponds to reference standard: PASS |
| Non-reduced CE-SDS |
>95% |
| SEC-HPLC |
>95% |
| Isoelectric Point |
Corresponds to reference standard |
| Bacterial Endotoxins Test |
|
| Residual Proteins of Host Cell |
|
| Exogenous Residual DNA |
|
| Residual protein A |
|
| Biological Activity |
|
| Osmolality |
Corresponds to reference standard: PASS |
| Peptide mapping |
Corresponds to reference standard: PASS |
| N-terminal sequence |
Corresponds to reference standard: PASS |
References
|
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470
Email:
sales@dcchemicals.com
order@dcchemicals.com
Website:
www.dcchemicals.com
|
